The real world experience of pediatric primary hyperoxaluria patients in the PEDSnet clinical research network

Christina B Ching1, Kimberley Dickinson2, John Karafilidis3

  • 1Department of Pediatric Urology, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA. christina.ching@nationwidechildrens.org.

PubMed

Insights

Primary hyperoxaluria (PH) in children requires significant healthcare, often involving kidney stones and transplants. Improved multidisciplinary specialist involvement could enhance diagnosis and treatment for PH patients.

Area of Science:

  • Pediatric Nephrology
  • Rare Diseases
  • Health Services Research

Background:

  • Primary hyperoxaluria (PH) is a rare metabolic disorder with significant renal and extra-renal implications.
  • Understanding the clinical care pathways and health service utilization in pediatric PH is crucial for improving patient outcomes.
  • Existing studies often focus on clinical manifestations or registries, with less emphasis on the comprehensive care journey.

Purpose of the Study:

  • To describe the clinical care course and health service utilization in a United States cohort of pediatric patients with primary hyperoxaluria (PH).
  • To identify patterns in diagnostic testing, interventions, and specialty care involvement for PH patients.
  • To highlight areas for improvement in the multidisciplinary management of pediatric PH.

Main Methods:

  • Retrospective cohort study of pediatric PH patients (<18 years) within the PEDSnet clinical research network (2009-2021).
  • Outcomes included diagnostic imaging, PH-specific interventions, and hospital service utilization, analyzed relative to cohort entrance date (CED).
  • Analysis of patient demographics, PH types (1, 2, 3), and follow-up duration.

Main Results:

  • Thirty-three pediatric PH patients were identified (23 PH type 1, 4 PH type 2, 6 PH type 3), with a median age of 5.0 years at CED.
  • High healthcare utilization observed, with 82% undergoing imaging for kidney stones and 46% requiring stone surgery.
  • Twelve percent needed dialysis (prior to CED) and 12% required renal or renal/liver transplant; multidisciplinary specialist involvement was limited (12%-36%).

Conclusions:

  • Pediatric PH patients in the U.S. experience substantial healthcare utilization, including significant renal interventions.
  • There are opportunities to enhance care by increasing the involvement of multidisciplinary specialists in PH management.
  • Optimizing specialty care coordination can potentially improve diagnosis, treatment, and prevention of PH complications.

Related Concept Videos

Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
522
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
3.6K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
36
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
42
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
45
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
59